Supervisory board

EQS-News: CPI PROPERTY GROUP – Final Results of the mandatory takeover offer for S IMMO

Retrieved on: 
Sunday, November 27, 2022

During the additional acceptance period which ended on 18 November 2022, 6,743,731 shares of S IMMO were tendered.

Key Points: 
  • During the additional acceptance period which ended on 18 November 2022, 6,743,731 shares of S IMMO were tendered.
  • Accordingly, following the settlement of the offer, CPIPG will control in aggregate 65,045,543 shares of S IMMO, which equals 88.37% of the share capital of S IMMO.
  • Upon settlement, CPIPG will hold 45,546,106 shares of S IMMO directly and 19,499,437 shares through our subsidiary IMMOFINANZ AG (IMMOFINANZ).
  • CPIPG has also proposed entering into negotiations with IMMOFINANZ concerning a potential purchase of S IMMO shares from CPIPG.

EQS-News: Mutares has successfully completed the acquisition of Götene Kyltransporter AB

Retrieved on: 
Sunday, November 27, 2022

Munich, 21 November 2022 Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has successfully completed the acquisition of all shares in Gtene Kyltransporter AB from private owners.

Key Points: 
  • Munich, 21 November 2022 Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has successfully completed the acquisition of all shares in Gtene Kyltransporter AB from private owners.
  • This is the second add-on acquisition for the Mutares portfolio company Frigoscandia in 2022 after the acquisition of Polar Frakt AS and the twelfth acquisition of Mutares in 2022.
  • Gtene Kyltransporter, headquartered in Gtene, Sweden, employs around 250 people and is a provider of temperature-controlled logistics.
  • The shares of Mutares SE & Co. KGaA are traded on the Regulated Market of the Frankfurt Stock Exchange under the symbol "MUX" (ISIN: DE000A2NB650).

EQS-News: SAF-HOLLAND SE appoints Frank Lorenz-Dietz, a financial expert with many years of industry experience, as new Chief Financial Officer

Retrieved on: 
Sunday, November 27, 2022

SAF-HOLLAND SE appoints Frank Lorenz-Dietz, a financial expert with many years of industry experience, as new Chief Financial Officer

Key Points: 
  • SAF-HOLLAND SE appoints Frank Lorenz-Dietz, a financial expert with many years of industry experience, as new Chief Financial Officer
    The issuer is solely responsible for the content of this announcement.
  • SAF-HOLLAND SE appoints Frank Lorenz-Dietz, a financial expert with many years of industry experience, as new Chief Financial Officer
    Bessenbach, Germany, November 17, 2022.
  • The Supervisory Board of SAF-HOLLAND SE has appointed Frank Lorenz-Dietz as Chief Financial Officer effective January1, 2023.
  • Frank Lorenz-Dietz Member of the Management Board and Chief Financial Officer (from Jan. 1, 2023)

EQS-News: VIB Vermögen AG resolves a capital increase against contribution in kind in the amount of EUR 4.87 million by way of using of authorized capital with exclusion of the subscription rights of the shareh

Retrieved on: 
Sunday, November 27, 2022

The issuer is solely responsible for the content of this announcement.

Key Points: 
  • The issuer is solely responsible for the content of this announcement.
  • VIB Vermgen AG informs about the following announcement of an insider information (ad hoc) as of today at 14:30 hrs:
    Announcement of an insider information due to Art.
  • 17 der Verordnung (EU) Nr.
  • The acquisition of the logistics portfolio and of the both management companies strengthens sustainably the growth of VIB Vermgen AG to be the leading logistics real estate AG as well as increases the business model of the VIB Vermgen AG to the management of logistics real estate for third parties which provides a high level of liquidity.

ASML Supervisory Board changes announced

Retrieved on: 
Wednesday, November 23, 2022

The Supervisory Board expresses its thanks to Gerard and Rolf-Dieter, who have served on the Supervisory Board since 2015, for their valuable contributions, in particular as Chairman of the Supervisory Board and Selection & Nomination Committee and as Chairman of the Audit Committee respectively.

Key Points: 
  • The Supervisory Board expresses its thanks to Gerard and Rolf-Dieter, who have served on the Supervisory Board since 2015, for their valuable contributions, in particular as Chairman of the Supervisory Board and Selection & Nomination Committee and as Chairman of the Audit Committee respectively.
  • The Supervisory Board intends to nominate Nils Andersen for appointment as a member of the Supervisory Board effective from the 2023 AGM, with the intention to elect him as Chairman following his appointment.
  • We are confident that the Supervisory Board will highly benefit from Nilss broad knowledge and leadership experience, said Annet Aris, Vice Chair of the Supervisory Board.
  • With his extensive experience at various multinational companies and his financial expertise, we are convinced that Jack will be a valuable contributor to the Supervisory Board, said Gerard Kleisterlee, Chairman of the Supervisory Board.

After seven years of accelerated growth at Rentschler Biopharma SE under his leadership as CEO, Dr. Frank Mathias to return to the Supervisory Board

Retrieved on: 
Monday, November 21, 2022

LAUPHEIM, Germany, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced, that following seven years of accelerated growth at Rentschler Biopharma under his leadership as Chief Executive Officer (CEO), Dr. Frank Mathias will return to the company’s Supervisory Board at the end of the fiscal year in March 2023. He will continue to be fully responsible for business operations while the Supervisory Board searches for a successor to be CEO.

Key Points: 
  • Dr. Frank Mathias joined Rentschler Biopharma SEs Supervisory Board in 2013 and was appointed Chief Executive Officer and Chairman of the Executive Board in April 2016.
  • Prof. Dr. Nikolaus F. Rentschler, Chairman of the Supervisory Board of Rentschler Biopharma, said: Under Dr. Frank Mathias responsible and thoughtful leadership, Rentschler Biopharma has experienced the most significant growth in its history, for which I would like to sincerely thank him.
  • Dr. Frank Mathias joined Rentschler Biopharmas Supervisory Board in 2013 and was appointed Chief Executive Officer and Chairman of the Executive Board in April 2016.
  • In Stevenage, UK, Rentschler Biopharma has launched a company dedicated to cell and gene therapies, Rentschler ATMP Ltd.

CENTOGENE Announces Changes to Supervisory Board, Including Appointment of Mary Sheahan

Retrieved on: 
Monday, November 21, 2022

Ms. Sheahan will serve as a member ad interim of the Companys Supervisory Board starting December 1, 2022.

Key Points: 
  • Ms. Sheahan will serve as a member ad interim of the Companys Supervisory Board starting December 1, 2022.
  • It is also planned that Ms. Sheahan will assume the role of Chair of the Audit Committee.
  • Ms. Sheahan currently serves as CFO of Avillion LLP, a private equity-backed life sciences company focused on the co-development and financing of pharmaceutical products.
  • We are very pleased to welcome Ms. Sheahan as a new member of the Supervisory Board, stated Peer Schatz, Chairman of the Supervisory Board of CENTOGENE.

Rentschler Biopharma appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board

Retrieved on: 
Wednesday, November 16, 2022

Prof. Dr. Nikolaus F. Rentschler, Chairman of the Supervisory Board of Rentschler Biopharma SE, said: I am very pleased that Christiane Bardroff will take on the important role of Chief Operating Officer.

Key Points: 
  • Prof. Dr. Nikolaus F. Rentschler, Chairman of the Supervisory Board of Rentschler Biopharma SE, said: I am very pleased that Christiane Bardroff will take on the important role of Chief Operating Officer.
  • Christiane is an experienced manager and an outstanding leader who has already achieved a lot since joining Rentschler Biopharma earlier this year.
  • Rentschler Biopharma is a family-owned company with about 1,100 employees, headquartered in Laupheim, Germany, with a second site in Milford, MA, USA.
  • In Stevenage, UK, Rentschler Biopharma has launched a company dedicated to cell and gene therapies, Rentschler ATMP Ltd.

Ahold Delhaize announces retirement of Kevin Holt, CEO Ahold Delhaize USA, at the 2023 Shareholder Meeting; JJ Fleeman, President of Peapod Digital Labs, to be nominated as CEO of Ahold Delhaize USA

Retrieved on: 
Tuesday, November 15, 2022

Ahold Delhaize will nominate JJ Fleeman as member of the Ahold Delhaize Management Board and CEO of Ahold Delhaize USA at the AGM.

Key Points: 
  • Ahold Delhaize will nominate JJ Fleeman as member of the Ahold Delhaize Management Board and CEO of Ahold Delhaize USA at the AGM.
  • JJs appointment to the Management Board of Ahold Delhaize is subject to shareholder approval at the AGM.
  • After the AGM, Kevin will remain with Ahold Delhaize USA in an advisory capacity until he retires at the end of 2023, to ensure a seamless transition.
  • JJ has served as President, Peapod Digital Labs and Chief Commercial and Digital Officer of Ahold Delhaize USA since May 2018.

Frank Elderson: Maintaining prudence when navigating unexpected tides and firming currents

Retrieved on: 
Saturday, November 26, 2022

Indeed, these were some of the main considerations when assessing the macroeconomic outlook in the euro area exactly one year ago.

Key Points: 
  • Indeed, these were some of the main considerations when assessing the macroeconomic outlook in the euro area exactly one year ago.
  • Today, a mild recession in the euro area around the turn of the year is quite plausible, as ECB President Christine Lagarde recently highlighted.
  • [1] Today, we face euro area inflation that continues to be far too high, having reached double digits in October.
  • Today, long-term interest rates in the euro area are around 2.5 percentage points higher than when I was first due to speak to you last year.
  • Today, as Bundesbank President Joachim Nagel said just last week, - muss die Geldpolitik auf der Hut sein.
  • The increase in interest rates reflects several steps in the monetary policy normalisation which the ECB started in December 2021.
  • As both an ECB Executive Board member and the Vice-Chair of the ECBs Supervisory Board, I am particularly interested in how banks adjust to the shifting macroeconomic tides.
  • More importantly, banks and we as supervisors need to be mindful that the increase in interest rates does not occur in isolation.
  • [3] Moreover while the macroeconomic tides may have changed, many of the structural challenges facing banks have not.
  • Indeed, the underlying currents which banks were already affected by last year, are still very much present.
  • In fact, important currents have even firmed with the change in tides.
  • While the prevailing macroeconomic tides and the inescapable currents of the climate and environment crises may have different causes, they nevertheless have something important in common.
  • This is especially true when assessing the configuration of tides and currents in conjunction, in other words, when assessing how the macroeconomic environment and the climate and environmental crises interact.